130 related articles for article (PubMed ID: 34407327)
1. Growth hormone replacement therapy: is it safe to use in children with asymptomatic pituitary lesions?
Sheldon BL; O'Brien MW; Adamo MA
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1525-1529. PubMed ID: 34407327
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and volumetry of pituitary cysts in children with growth hormone deficiency and idiopathic short stature.
Krasnow N; Pogostin B; Haigney J; Groh B; Weiler W; Tenner M; Kessler M; Frey M; Noto RA
J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1267-1271. PubMed ID: 30367806
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma.
van Iersel L; van Santen HM; Potter B; Li Z; Conklin HM; Zhang H; Chemaitilly W; Merchant TE
Pediatr Blood Cancer; 2020 Dec; 67(12):e28723. PubMed ID: 33037871
[TBL] [Abstract][Full Text] [Related]
4. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
[TBL] [Abstract][Full Text] [Related]
6. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
7. Incidental Pituitary Cysts in Children: Does Growth Hormone Treatment Affect Cyst Size?
Baird K; McCroskey J; Arynchyna A; Abdullatif H; Ashraf AP; Simpson L; Rocque BG
Endocr Pract; 2021 Nov; 27(11):1128-1132. PubMed ID: 33965583
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive function in adults with growth hormone deficiency.
van Dam PS
Horm Res; 2005; 64 Suppl 3():109-14. PubMed ID: 16439853
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001.
Thomas M; Massa G; Craen M; de Zegher F; Bourguignon JP; Heinrichs C; De Schepper J; Du Caju M; Thiry-Counson G; Maes M
Eur J Endocrinol; 2004 Jul; 151(1):67-72. PubMed ID: 15248824
[TBL] [Abstract][Full Text] [Related]
10. Deterioration of growth hormone (GH) response and anterior pituitary function in young adults with childhood-onset GH deficiency and ectopic posterior pituitary: a two-year prospective follow-up study.
di Iorgi N; Secco A; Napoli F; Tinelli C; Calcagno A; Fratangeli N; Ambrosini L; Rossi A; Lorini R; Maghnie M
J Clin Endocrinol Metab; 2007 Oct; 92(10):3875-84. PubMed ID: 17666476
[TBL] [Abstract][Full Text] [Related]
11. Effect of growth hormone therapy on thyroid function in isolated growth hormone deficient and short small for gestational age children: a two-year study, including on assessment of the usefulness of the thyrotropin-releasing hormone (TRH) stimulation test.
Ebuchi Y; Kubo T; Furujo M; Higuchi Y; Fujinaga S; Tsuchiya H; Urata N; Ochi M; Namba T; Hara N; Kishi M
J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1417-1423. PubMed ID: 33035188
[TBL] [Abstract][Full Text] [Related]
12. The evolution of pituitary cysts in growth hormone-treated children.
Krasnow MD; Krasnow NA; McGuirk L; Patale TP; Manely S; Sayegh E; Epstein B; Hanif SA; Mehta S; Tenner M; Schefflein J; Mehta H; Noto RA
J Pediatr Endocrinol Metab; 2023 Jan; 36(1):36-42. PubMed ID: 36394493
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database).
Maghnie M; Lindberg A; Koltowska-Häggström M; Ranke MB
Eur J Endocrinol; 2013 Feb; 168(2):211-7. PubMed ID: 23152438
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Outcomes of Pituitary Microadenomas in Children with Short Stature/Growth Hormone Deficiency.
Derrick KM; Gomes WA; Gensure RC
Horm Res Paediatr; 2018; 90(3):151-160. PubMed ID: 30261514
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
[TBL] [Abstract][Full Text] [Related]
16. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
[TBL] [Abstract][Full Text] [Related]
18. Brain MRIs may be of low value in most children diagnosed with isolated growth hormone deficiency.
Schmitt J; Thornton P; Shah AN; Rahman AKMF; Kubota E; Rizzuto P; Gupta A; Orsdemir S; Kaplowitz PB
J Pediatr Endocrinol Metab; 2021 Mar; 34(3):333-340. PubMed ID: 33618442
[TBL] [Abstract][Full Text] [Related]
19. Is Gadolinium Contrast Necessary for Pituitary MRI in the Evaluation of Pediatric Short Stature and Growth Hormone Deficiency?
Almaghraby A; Jaju A; Ryan ME; Rychlik K; Habiby RL; Brickman WJ
Horm Res Paediatr; 2021; 94(5-6):201-210. PubMed ID: 34425574
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
